$SER
Serina Therapeutics Inc

2022 Q4 Form 10-Q Financial Statement

#000149315222031357 Filed on November 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $8.000K $9.000K $24.00K
YoY Change -70.37% -62.5% -65.22%
Cost Of Revenue $1.000K $5.000K $2.000K
YoY Change 0.0% 150.0% -88.24%
Gross Profit $7.000K $4.000K $22.00K
YoY Change -73.08% -81.82% -57.69%
Gross Profit Margin 87.5% 44.44% 91.67%
Selling, General & Admin $1.581M $1.392M $1.421M
YoY Change 4.22% -2.04% -20.88%
% of Gross Profit 22585.71% 34800.0% 6459.09%
Research & Development $175.0K $162.0K $243.0K
YoY Change -48.98% -33.33% -60.81%
% of Gross Profit 2500.0% 4050.0% 1104.55%
Depreciation & Amortization $33.00K $33.00K $32.00K
YoY Change 0.0% 3.13% -87.83%
% of Gross Profit 471.43% 825.0% 145.45%
Operating Expenses $1.789M $1.554M $1.696M
YoY Change -5.49% -8.37% -30.75%
Operating Profit -$1.782M -$1.550M -$1.674M
YoY Change -4.55% -7.41% -30.16%
Interest Expense -$978.0K $923.0K -$285.0K
YoY Change 231.53% -423.86% 124.41%
% of Operating Profit
Other Income/Expense, Net -$1.000K -$886.0K $4.000K
YoY Change -133.33% -22250.0%
Pretax Income -$2.761M -$2.436M -$1.955M
YoY Change 27.88% 24.6% -22.54%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$2.703M -$2.435M -$1.955M
YoY Change 25.25% 24.55% -23.12%
Net Earnings / Revenue -33787.5% -27055.56% -8145.83%
Basic Earnings Per Share -$0.06 -$0.05
Diluted Earnings Per Share -$0.07 -$64.17K -$51.53K
COMMON SHARES
Basic Shares Outstanding 37.95M shares 37.95M shares 37.94M shares
Diluted Shares Outstanding 37.95K shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $645.0K $466.0K $731.0K
YoY Change 10.45% -36.25% -33.97%
Cash & Equivalents $645.0K $466.0K $731.0K
Short-Term Investments
Other Short-Term Assets $1.804M $720.0K $720.0K
YoY Change 11.02% 0.0% 23.92%
Inventory
Prepaid Expenses
Receivables $4.000K $1.000K $24.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.453M $1.187M $1.475M
YoY Change 9.8% -19.53% -23.54%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $738.0K $771.0K
YoY Change -15.17%
Long-Term Investments
YoY Change
Other Assets $50.00K $50.00K $50.00K
YoY Change 0.0% 0.0% -50.0%
Total Long-Term Assets $788.0K $821.0K $952.0K
YoY Change -14.35% -13.76% -58.14%
TOTAL ASSETS
Total Short-Term Assets $2.453M $1.187M $1.475M
Total Long-Term Assets $788.0K $821.0K $952.0K
Total Assets $3.241M $2.008M $2.427M
YoY Change 2.76% -17.26% -42.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $568.0K $351.0K $184.0K
YoY Change 194.3% 90.76% -79.3%
Accrued Expenses $273.0K $441.0K $740.0K
YoY Change -52.77% -40.41% -27.88%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $7.646M $7.298M $5.600M
YoY Change 7.09% 30.32% 197.24%
Total Short-Term Liabilities $10.08M $8.809M $6.598M
YoY Change 12.39% 33.51% 35.93%
LONG-TERM LIABILITIES
Long-Term Debt $10.48M $8.348M $5.807M
YoY Change 72.85% 43.76% 87.63%
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $10.48M $8.348M $5.807M
YoY Change 72.85% 43.76% 87.63%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.08M $8.809M $6.598M
Total Long-Term Liabilities $10.48M $8.348M $5.807M
Total Liabilities $20.56M $17.16M $12.36M
YoY Change 36.78% 38.78% 57.41%
SHAREHOLDERS EQUITY
Retained Earnings -$116.2M -$113.5M
YoY Change 9.88%
Common Stock $4.000K $4.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$17.21M -$15.10M -$9.936M
YoY Change
Total Liabilities & Shareholders Equity $3.241M $2.008M $2.427M
YoY Change 2.76% -17.26% -42.26%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$2.703M -$2.435M -$1.955M
YoY Change 25.25% 24.55% -23.12%
Depreciation, Depletion And Amortization $33.00K $33.00K $32.00K
YoY Change 0.0% 3.13% -87.83%
Cash From Operating Activities -$1.321M -$1.236M -$1.884M
YoY Change -19.79% -34.39% -0.26%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.500M 1.000M 2.000M
YoY Change 20.0% -50.0% 1.16%
NET CHANGE
Cash From Operating Activities -1.321M -1.236M -1.884M
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 1.500M 1.000M 2.000M
Net Change In Cash 179.0K -236.0K 116.0K
YoY Change -221.77% -303.45% 52.63%
FREE CASH FLOW
Cash From Operating Activities -$1.321M -$1.236M -$1.884M
Capital Expenditures $0.00
Free Cash Flow -$1.884M
YoY Change 0.37%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001708599
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q4 AGE Warrant Liability
WarrantLiability
usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q3 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
usd
CY2021Q3 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
usd
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
usd
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
usd
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
usd
CY2021Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
usd
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest
usd
CY2021Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest
usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest
usd
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2021Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
usd
CY2021Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
usd
CY2021Q3 AGE Less Comprehensive Loss Attributable To Noncontrolling Interest From Continuing Operations
LessComprehensiveLossAttributableToNoncontrollingInterestFromContinuingOperations
usd
CY2022Q3 AGE Other Comprehensive Income Loss Attributable To Noncontrolling Interest From Discontinued Operations
OtherComprehensiveIncomeLossAttributableToNoncontrollingInterestFromDiscontinuedOperations
usd
CY2021Q3 AGE Other Comprehensive Income Loss Attributable To Noncontrolling Interest From Discontinued Operations
OtherComprehensiveIncomeLossAttributableToNoncontrollingInterestFromDiscontinuedOperations
usd
AGE Other Comprehensive Income Loss Attributable To Noncontrolling Interest From Discontinued Operations
OtherComprehensiveIncomeLossAttributableToNoncontrollingInterestFromDiscontinuedOperations
usd
AGE Gain On Deconsolidation Of Lifemap Sciences
GainOnDeconsolidationOfLifemapSciences
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
usd
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
usd
us-gaap Proceeds From Collection Of Longterm Loans To Related Parties
ProceedsFromCollectionOfLongtermLoansToRelatedParties
usd
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
usd
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
usd
CY2021Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
usd
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
shares
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
CY2021Q4 AGE Warrant Liability
WarrantLiability
usd
AGE Unrealized Loss On Change In Fair Value Of Warrants
UnrealizedLossOnChangeInFairValueOfWarrants
usd
AGE Unrealized Loss On Change On Other Than Options
UnrealizedLossOnChangeOnOtherThanOptions
shares
AGE Unrealized Loss On Change In Fair Value Of Warrants Per Share
UnrealizedLossOnChangeInFairValueOfWarrantsPerShare
us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
usd
us-gaap Short Term Debt Refinanced Amount
ShortTermDebtRefinancedAmount
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-38519
dei Entity Registrant Name
EntityRegistrantName
AgeX Therapeutics, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-1436829
dei Entity Address Address Line1
EntityAddressAddressLine1
1101 Marina Village Parkway
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 201
dei Entity Address City Or Town
EntityAddressCityOrTown
Alameda
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94501
dei City Area Code
CityAreaCode
(510)
dei Local Phone Number
LocalPhoneNumber
671-8370
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
AGE
dei Security Exchange Name
SecurityExchangeName
NYSEAMER
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
37947152 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
466000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
584000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
25000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
720000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1625000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
1187000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
2234000 usd
CY2022Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
50000 usd
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
50000 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
771000 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
870000 usd
CY2022Q3 us-gaap Assets
Assets
2008000 usd
CY2021Q4 us-gaap Assets
Assets
3154000 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
792000 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
771000 usd
CY2022Q3 us-gaap Loans Payable Current
LoansPayableCurrent
7298000 usd
CY2021Q4 us-gaap Loans Payable Current
LoansPayableCurrent
7140000 usd
CY2022Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
59000 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
70000 usd
CY2022Q3 AGE Warrant Liability
WarrantLiability
657000 usd
CY2022Q3 AGE Insurance Premium Liability And Other Current Liabilities
InsurancePremiumLiabilityAndOtherCurrentLiabilities
3000 usd
CY2021Q4 AGE Insurance Premium Liability And Other Current Liabilities
InsurancePremiumLiabilityAndOtherCurrentLiabilities
986000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
8809000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8967000 usd
CY2022Q3 us-gaap Minority Interest
MinorityInterest
-45000 usd
CY2022Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
8348000 usd
CY2021Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
6062000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
17157000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
15029000 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37947000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37947000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37941000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37941000 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
4000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
4000 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
98399000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
93912000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-113507000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-105748000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-15104000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-11832000 usd
CY2021Q4 us-gaap Minority Interest
MinorityInterest
-43000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-15149000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-11875000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2008000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3154000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
117000 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
5000 usd
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
2000 usd
us-gaap Cost Of Revenue
CostOfRevenue
12000 usd
us-gaap Cost Of Revenue
CostOfRevenue
18000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
4000 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
22000 usd
us-gaap Gross Profit
GrossProfit
14000 usd
us-gaap Gross Profit
GrossProfit
99000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
162000 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
275000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
817000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1080000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1392000 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1421000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4390000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5191000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
1554000 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
1696000 usd
us-gaap Operating Expenses
OperatingExpenses
5207000 usd
us-gaap Operating Expenses
OperatingExpenses
6271000 usd
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
106000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1550000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1674000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-5193000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-6066000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
923000 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
285000 usd
us-gaap Interest Expense
InterestExpense
2357000 usd
us-gaap Interest Expense
InterestExpense
802000 usd
CY2022Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-35000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
220000 usd
CY2022Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
2000 usd
CY2021Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
4000 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
9000 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
445000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-886000 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-281000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2568000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-357000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2436000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1955000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7761000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6423000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-103000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-2436000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-1955000 usd
us-gaap Profit Loss
ProfitLoss
-7761000 usd
us-gaap Profit Loss
ProfitLoss
-6526000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
1000 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2000 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest
-7000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2435000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1955000 usd
us-gaap Net Income Loss
NetIncomeLoss
-7759000 usd
us-gaap Net Income Loss
NetIncomeLoss
-6517000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.06
CY2021Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.05
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.20
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.17
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37946000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37938000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37944000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37868000 shares
CY2022Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-2435000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-1955000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-7759000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-6421000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-96000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2435000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1955000 usd
us-gaap Net Income Loss
NetIncomeLoss
-7759000 usd
us-gaap Net Income Loss
NetIncomeLoss
-6517000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-2436000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-1955000 usd
us-gaap Profit Loss
ProfitLoss
-7761000 usd
us-gaap Profit Loss
ProfitLoss
-6526000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-143000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2436000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1955000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7761000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6669000 usd
CY2022Q3 AGE Less Comprehensive Loss Attributable To Noncontrolling Interest From Continuing Operations
LessComprehensiveLossAttributableToNoncontrollingInterestFromContinuingOperations
1000 usd
AGE Less Comprehensive Loss Attributable To Noncontrolling Interest From Continuing Operations
LessComprehensiveLossAttributableToNoncontrollingInterestFromContinuingOperations
2000 usd
AGE Less Comprehensive Loss Attributable To Noncontrolling Interest From Continuing Operations
LessComprehensiveLossAttributableToNoncontrollingInterestFromContinuingOperations
2000 usd
AGE Other Comprehensive Income Loss Attributable To Noncontrolling Interest From Discontinued Operations
OtherComprehensiveIncomeLossAttributableToNoncontrollingInterestFromDiscontinuedOperations
7000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2435000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1955000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-7759000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6660000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7759000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
6421000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2000 usd
AGE Gain On Deconsolidation Of Lifemap Sciences
GainOnDeconsolidationOfLifemapSciences
106000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
437000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
220000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
99000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
98000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2221000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
820000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
646000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
736000 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-24000 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-129000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-906000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-682000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-98000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-619000 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
110000 usd
us-gaap Increase Decrease In Insurance Liabilities
IncreaseDecreaseInInsuranceLiabilities
-983000 usd
us-gaap Increase Decrease In Insurance Liabilities
IncreaseDecreaseInInsuranceLiabilities
-921000 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-2000 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-77000 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4618000 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-6118000 usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-90000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4618000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6208000 usd
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
466000 usd
us-gaap Proceeds From Collection Of Longterm Loans To Related Parties
ProceedsFromCollectionOfLongtermLoansToRelatedParties
250000 usd
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
716000 usd
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-50000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
666000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
4500000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
5500000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
496000 usd
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
4500000 usd
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
5996000 usd
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
-250000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4500000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5746000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-118000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
204000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
634000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
577000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
516000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
781000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-113500000 usd
CY2022Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
500000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
442000 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
771000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_844_eus-gaap--UseOfEstimates_z9L8r50VGqi6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86E_zhdtejWHswbb">Use of estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from the estimates. See Note 6 for discussion on estimated unrealized loss on change in fair value of warrant liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3 AGE Warrant Liability
WarrantLiability
657000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
466000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
584000 usd
CY2022Q3 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
50000 usd
CY2021Q4 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
50000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
516000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
634000 usd
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P10Y
us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
(i) 75% or greater to determine whether the lease term is a major part of the remaining economic life of the underlying asset and (ii) 90% or greater to determine whether the present value of the sum of lease payments is substantially all of the fair value of the underlying asset
CY2020Q4 us-gaap Payments For Rent
PaymentsForRent
947 usd
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
277000 usd
us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
-380000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-103000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest
-7000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-96000 usd
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
106000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1312000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1312000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
541000 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
870000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
33000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
99000 usd
CY2021Q3 AGE Depreciation And Amortization Continued Operations
DepreciationAndAmortizationContinuedOperations
32000 usd
AGE Depreciation And Amortization Continued Operations
DepreciationAndAmortizationContinuedOperations
98000 usd
us-gaap Depreciation And Amortization Discontinued Operations
DepreciationAndAmortizationDiscontinuedOperations
89000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
32000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
131000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
131000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
132000 usd
CY2022Q3 AGE Finite Lived Intangible Assets Amortization Expense After Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree
345000 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
771000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
351000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
193000 usd
CY2022Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
180000 usd
CY2021Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
212000 usd
CY2022Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
261000 usd
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
366000 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
792000 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
771000 usd
CY2022Q3 us-gaap Common Stock Held By Subsidiary
CommonStockHeldBySubsidiary
250000 usd
CY2022Q3 us-gaap Line Of Credit
LineOfCredit
26160000 usd
CY2022Q3 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
728000 usd
CY2022Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
7160000 usd
CY2022Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
19728000 usd
CY2022Q3 us-gaap Deferred Finance Costs Noncurrent Gross
DeferredFinanceCostsNoncurrentGross
7960000 usd
CY2022Q3 us-gaap Accumulated Amortization Of Noncurrent Deferred Finance Costs
AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts
3877000 usd
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
15646000 usd
CY2022Q3 us-gaap Secured Debt
SecuredDebt
13160000 usd
CY2022Q3 us-gaap Secured Debt
SecuredDebt
13160000 usd
AGE Changes In Fair Value
ChangesInFairValue
220000 usd
CY2022Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
2000000 usd
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1639344 shares
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.4008
CY2022Q3 AGE Warrant Liability
WarrantLiability
657000 usd
CY2022Q3 AGE Changes In Fair Value Of Warant Liability
ChangesInFairValueOfWarantLiability
35000 usd
AGE Changes In Fair Value Of Warant Liability
ChangesInFairValueOfWarantLiability
220000 usd
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37947152 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37947152 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37941220 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37941220 shares
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-13262000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-13262000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-1000 usd
CY2022Q3 AGE Fair Value Of Liability Classified Warrants Issued
FairValueOfLiabilityClassifiedWarrantsIssued
341000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
209000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-2436000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-15149000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-15149000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-11875000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-11875000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-3000 usd
AGE Fair Value Of Warrants Issued
FairValueOfWarrantsIssued
178000 usd
AGE Fair Value Of Liability Classified Warrants Issued
FairValueOfLiabilityClassifiedWarrantsIssued
3666000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
646000 usd
us-gaap Profit Loss
ProfitLoss
-7761000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-15149000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-15149000 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-8294000 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-8294000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-1000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
272000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-1955000 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-9978000 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-9978000 usd
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-5396000 usd
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-5396000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
475000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-6000 usd
AGE Fair Value Of Warrants Issued
FairValueOfWarrantsIssued
757000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
740000 usd
AGE Deconsolidation Of Lifemap Sciences
DeconsolidationOfLifemapSciences
-22000 usd
us-gaap Profit Loss
ProfitLoss
-6526000 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-9978000 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-9978000 usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
209000 usd
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
272000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
646000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
736000 usd
AGE Share Based Compensation From Discontinued Operations
ShareBasedCompensationFromDiscontinuedOperations
4000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.79
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.46
us-gaap Accelerated Share Repurchases Final Price Paid Per Share
AcceleratedShareRepurchasesFinalPricePaidPerShare
0.79
us-gaap Accelerated Share Repurchases Final Price Paid Per Share
AcceleratedShareRepurchasesFinalPricePaidPerShare
1.46
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y6M29D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y8M15D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.3071 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.0234 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0174 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0099 pure
us-gaap Interest Paid Net
InterestPaidNet
14000 usd
us-gaap Interest Paid Net
InterestPaidNet
13000 usd
AGE Issuance Of Common Stock Upon Vesting Of Restricted Stock Units
IssuanceOfCommonStockUponVestingOfRestrictedStockUnits
6000 usd
AGE Issuance Of Common Stock Upon Vesting Of Restricted Stock Units
IssuanceOfCommonStockUponVestingOfRestrictedStockUnits
14000 usd
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
178000 usd
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
757000 usd
us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
3666000 usd
us-gaap Short Term Debt Refinanced Amount
ShortTermDebtRefinancedAmount
7160000 usd
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
2000000 usd

Files In Submission

Name View Source Status
0001493152-22-031357-index-headers.html Edgar Link pending
0001493152-22-031357-index.html Edgar Link pending
0001493152-22-031357.txt Edgar Link pending
0001493152-22-031357-xbrl.zip Edgar Link pending
age-20220930.xsd Edgar Link pending
ex31.htm Edgar Link pending
ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
form10-q_htm.xml Edgar Link completed
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
age-20220930_cal.xml Edgar Link unprocessable
age-20220930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
age-20220930_def.xml Edgar Link unprocessable
age-20220930_pre.xml Edgar Link unprocessable